Trinity Bivalacqua

Associate Professor

If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Erectile Dysfunction Medicine & Life Sciences
Urinary Bladder Neoplasms Medicine & Life Sciences
Penis Medicine & Life Sciences
Priapism Medicine & Life Sciences
Cystectomy Medicine & Life Sciences
Blood Vessels Medicine & Life Sciences
Prostatectomy Medicine & Life Sciences
Penile Induration Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2018

Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry

Blue Light Cystoscopy with Cysview Registry Group Jan 1 2018 (Accepted/In press) In : Urologic Oncology: Seminars and Original Investigations.

Research output: Contribution to journalArticle

Urinary Bladder Neoplasms
Carcinoma in Situ

Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method

Chalfin, H. J., Kates, M., van der Toom, E. E., Glavaris, S., Verdone, J. E., Hahn, N. M., Pienta, K. J., Bivalacqua, T. J. & Gorin, M. A. Jan 1 2018 (Accepted/In press) In : Urology.

Research output: Contribution to journalArticle

Circulating Neoplastic Cells
Urinary Bladder Neoplasms

Characterization of voiding function and structural bladder changes in a rat model of neurogenic underactive bladder disease

Weyne, E., Dewulf, K., Deruyer, Y., Rietjens, R., Everaerts, W., Bivalacqua, T. J., De Ridder, D., Van der Aa, F. & Albersen, M. Jan 1 2018 (Accepted/In press) In : Neurourology and Urodynamics.

Research output: Contribution to journalArticle

Urinary Bladder Diseases
Neurogenic Urinary Bladder
Urinary Bladder
Smooth Muscle Myocytes
Drug Therapy
Control Groups

Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy

Vasdev, N. , Zargar, H. , Noël, J. P. , Veeratterapillay, R. , Fairey, A. S. , Mertens, L. S. , Dinney, C. P. , Mir, M. C. , Krabbe, L. M. , Cookson, M. S. , Jacobsen, N. E. , Gandhi, N. M. , Griffin, J. , Montgomery, J. S. , Yu, E. Y. , Xylinas, E. , Campain, N. J. , Kassouf, W. , Dall’Era, M. A. , Seah, J. A. & 21 others Ercole, C. E., Horenblas, S., Sridhar, S. S., McGrath, J. S., Aning, J., Shariat, S. F., Wright, J. L., Morgan, T. M., Bivalacqua, T. J., North, S., Barocas, D. A., Lotan, Y., Grivas, P., Stephenson, A. J., Shah, J. B., van Rhijn, B. W., Daneshmand, S., Spiess, P. E., Holzbeierlein, J. M., Thorpe, A. & Black, P. C. Jun 7 2018 (Accepted/In press) In : World Journal of Urology. p. 1-8 8 p.

Research output: Contribution to journalArticle

Induction Chemotherapy
Carcinoma in Situ
Urinary Bladder Neoplasms
Drug Therapy